RFID Moves Forward - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

RFID Moves Forward
Many radio frequency identification projects are moving beyond the pilot stage, supported by new hardware and software tools.


Pharmaceutical Technology




The pharmaceutical industry continues to embrace radio frequency identification (RFID) technology. Pilot projects are demonstrating proof-of-concept and moving beyond compliance with retailer mandates to identify ways to benefit internally from the product visibility data RFID makes available. Several companies have made the move to full-scale implementation. Maturing hardware and software tools bring higher functionality with less customization.

E-pedigree study

An end-to-end e-pedigree pilot undertaken in 2006 by Cardinal Health, Inc. (Dublin, OH, http://www.cardinal.com/) indicates pallet- and case-level ultrahigh-frequency (UHF) tagging works better than item-level tagging at present, but it still needs improvement to achieve read rates above 99% consistently (see "Tagging Tools to Provide E-Pedigree, Pharmaceutical Technology, September 2006). "A great deal of additional work needs to be undertaken by stakeholders across the industry to address significant challenges [related to item-level tagging], including global standards, privacy concerns, and the safe handling of biologics," says Renard Jackson, vice-president and general manager of global packaging services for Cardinal. "Until those challenges are addressed, direct distribution of medicine continues to be the best near-term approach to maintain the highest levels of security and efficiency in the pharmaceutical supply chain," he states. Jackson concludes, however,"Cardinal Health's test of RFID under real-world conditions has demonstrated that the technology has real promise to provide an added layer of safety."


Hallie Forcinio
The Cardinal study also found that tag encoding and application can occur at line speeds with minimal adjustments to current labeling and packaging lines. On-line encoding yields ranged between 95% and 97% but could approach 100% with some fine-tuning of the process.

Item-level read rates varied from less than 10% to nearly 100%, depending on the product, situation, and read location. In general, primary packages read well when cases were scanned one at a time. Item-level read rates decreased when full pallets were scanned and at read points beyond the unit-to-case aggregation point. Read rates for tagged product in mixed-product totes varied.

At the case level, full-pallet loads often can be read at 100%. Further testing is needed to determine whether process changes and hardware tuning can achieve 100% read rates consistently. It also may be necessary to use bar code technology to complement and serve as a back-up to RFID.

Full-scale implementations

Another pioneer in RFID technology, Purdue Pharma L.P. (Stamford, CT, http://www.purduepharma.com/), is deploying item-level tagging to improve pharmaceutical supply-chain efficiency and security and enable e-pedigree recordkeeping (see "Tagging Tools to Provide E-Pedigree," Pharmaceutical Technology, September 2006). The company is achieving 100% read reliability and exceeding read-rate requirements with UHF electronic product code (EPC) Class 1 Gen 2 technology (RFID tags equipped with "Monza" chips, "Speedway" RFID readers, and near-field antennas from Impinj, Inc., (Seattle, WA, http://www.impinj.com/).

Tracking software certifies, captures, and analyzes the data from the RFID tags ("TIPS" serialized product-tracking solution, SYSTECH International, Cranbury, NJ, http://www.systech-tips.com/). "The ... technology has been selected as an integral part of our packaging-line improvements to help the company establish an e-pedigree process that will significantly improve the delivery of products from the factory to the pharmacy counter," says Aaron Graham, vice-president of corporate security and chief security officer at Purdue Pharma.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here